Daybreak is a custom-fit mandibular advancement device for mild-to-moderate obstructive sleep apnea. The device is FDA-cleared, prescribed by board-certified physicians, and delivered entirely through a remote telehealth pathway from your home.
A peer-reviewed study published in the American Journal of Clinical and Medical Research found Daybreak reduced the apnea-hypopnea index by 63.3% in mild OSA patients and 60.95% in moderate OSA patients. Eighty-three percent of the 185 Cedars-Sinai patients met treatment success criteria. The device also covers the at-home sleep test, impressions, titration, and follow-up support.
Reviews are split. Some users report immediate symptom relief and praise the convenience of the remote process. Others describe long delays, poor communication, and unresolved device problems. Here is what the evidence and user feedback actually show.
What Is Daybreak Sleep Apnea?
Daybreak is a custom-fit mandibular advancement device built to treat mild-to-moderate obstructive sleep apnea without a CPAP mask. The device holds the lower jaw slightly forward during sleep. Jaw advancement keeps the upper airway from collapsing. Daybreak is FDA-cleared and dispensed through a telehealth pathway run by board-certified physicians and dentists.
Obstructive sleep apnea (OSA) occurs when throat muscles relax and block the airway during sleep. Breathing pauses, loud snoring, and fragmented sleep follow. Untreated OSA raises the risk of high blood pressure, heart disease, and stroke. Daytime fatigue and memory problems compound the health burden.
Daybreak serves adults with mild-to-moderate OSA who cannot tolerate a CPAP machine. CPAP applies pressurized air through a mask to hold the airway open. Many patients abandon CPAP within months. Daybreak’s oral device fits like a retainer and generates no noise, no mask pressure, and no tubing.
How Does Daybreak Work for Sleep Apnea?
The Daybreak device works by repositioning the lower jaw forward up to 3 to 4 millimeters (0.12 to 0.16 inches) during sleep to keep the upper airway clear. The tongue and soft palate shift forward with the jaw. Airway obstruction clears. Snoring and apnea events decrease or stop entirely.
Daybreak uses a titration process to find each patient’s effective jaw position. The device starts at 1 millimeter (0.04 inches) of advancement. Titration increases by 1 millimeter each week through guided virtual check-ins. Most patients reach an effective position within several weeks.
The treatment pathway runs entirely from home. A patient takes a two-night at-home sleep test first. A board-certified physician reviews the data and prescribes the device. The patient completes dental impressions at home using a kit Daybreak ships out. The finished custom appliance ships directly back to the patient.
Who Makes the Daybreak Device?
Daybreak is a telehealth company that developed a fully remote pathway for sleep apnea diagnosis and mandibular advancement device therapy. The company pairs patients with board-certified physicians and licensed dentists. Peter Balacky, DDS, serves as Daybreak’s dental director and oversees the clinical treatment program.
A retrospective cohort study conducted at Cedars-Sinai Medical Center evaluated 185 patients who used Daybreak’s telehealth-guided system. Results were published in the American Journal of Clinical and Medical Research in January 2026. Investigators found the virtual pathway achieved significant AHI reductions comparable to traditional in-clinic care models.
Daybreak also uses the WatchPAT for at-home sleep testing. WatchPAT is an FDA-cleared wrist and finger device that measures key sleep breathing indicators. Test data transmits to Daybreak’s physician team for analysis. Results arrive within 24 hours of completing the two-night study.
What Are the Benefits of the Daybreak Device?
Daybreak provides a mask-free, portable sleep apnea treatment that runs entirely from home, from diagnosis through titration and follow-up care. The device fits like a retainer and is easy to travel with. FSA-eligible pricing and insurance coverage reduce out-of-pocket costs for most patients.
Here’s the thing: access is the biggest advantage. The entire process requires no clinic visits, no sleep lab bookings, and no long referral chains. Patients who live far from sleep specialists or who find scheduling impossible benefit most from the remote model.
The at-home sleep test also stands out as a strong entry point. The test takes two nights and costs under $60 (USD) in some promotions. Results from a board-certified physician review arrive within 24 hours. Peter Balacky, DDS, stated the goal is to ‘expand access to care while maintaining the highest clinical standards.’
Key Benefits:
- FDA-cleared for mild-to-moderate obstructive sleep apnea and snoring
- Fully remote pathway from diagnosis to device delivery
- Custom fit produced from at-home dental impressions
- Covered by most medical insurance plans and FSA-eligible
- No clinic visits, no sleep lab, no waiting rooms
Does Daybreak Actually Reduce Sleep Apnea Events?
Yes. The Daybreak device reduced the apnea-hypopnea index (AHI) by 63.3% in mild OSA patients and 60.95% in moderate OSA patients in a Cedars-Sinai Medical Center study. Mild OSA AHI dropped from 9.08 to 3.33 events per hour. Moderate OSA AHI dropped from 22 to 8.59 events per hour. Overall, 83% of the 185 patients met Sleep Health Experts Recommendations (SHER) treatment success criteria.
The numbers matter. Among mild OSA patients, 88% reached a post-treatment AHI below 5 events per hour. That threshold defines normal breathing during sleep. The Cedars-Sinai cohort also found 95% of mild OSA patients achieved an AHI below 10 events per hour after treatment.
Snoring improved alongside the objective data. Eighty-two percent of patients in the same study reported subjective snoring improvement. The titration protocol started at 1 millimeter of advancement. Patients saw improvement with minimal jaw repositioning. The protocol reduces the risk of discomfort during the adjustment period.
Does Daybreak Work Better Than CPAP?
No. CPAP remains the gold standard for obstructive sleep apnea treatment and consistently achieves higher AHI reduction rates than oral appliances across all severity levels. A two-year follow-up clinical trial comparing CPAP to mandibular advancement devices found CPAP produced lower AHI scores overall. Both treatments, though, produced similar improvements in daytime sleepiness scores and quality-of-life measures.
That said, compliance tells a different story. CPAP requires wearing a pressurized mask every night. Many patients abandon CPAP within the first year due to discomfort and inconvenience. Daybreak’s retainer-style device generates no noise and no mask pressure. For mild-to-moderate OSA, consistent use of an oral appliance often beats inconsistent CPAP use.
The ideal choice depends on OSA severity. Patients with severe OSA should use CPAP as the primary treatment. Patients with mild-to-moderate OSA who cannot tolerate CPAP are the right candidates for Daybreak. A sleep physician should guide the decision using polysomnographic data and the patient’s documented AHI score.
What Do Daybreak Sleep Apnea Reviews Say?
Daybreak holds a 3.0 out of 5 score on Trustpilot. Satisfied users report strong symptom relief. Frustrated customers report delays, poor communication, and unresolved device problems. The pattern is consistent: patients who receive a well-fitted device on time tend to be happy. Those who hit process problems rate the experience poorly.
The at-home sleep test earns consistent praise. One reviewer noted the WatchPAT test ‘accurately showed my sleep apnea events, REM cycle timing, and my overall oxygenation.’ Results arrived within 24 hours. The experience was described as ‘a modern and efficient way to get diagnosed.’
Customer service is the most contested area. Positive reviewers describe representatives who were ‘incredibly knowledgeable, patient, and supportive.’ Negative reviewers report ignored emails, missed appointments, and phones that went unanswered for months. Worth knowing: both patterns appear in recent 2026 reviews, not just older ones.
What Are the Positive Daybreak Reviews?
Positive Daybreak reviewers consistently report quick symptom relief, improved sleep quality, and a comfortable device that requires little adjustment time. One user wrote the device ‘ended my sleep apnea symptoms immediately.’ A second described the mouthpiece as ‘incredibly comfortable’ and reported that snoring reduced so much their partner ‘hardly hears me at night anymore.’
Reviews also praise the speed of the at-home process. Users describe getting fitted without visiting dentists, doctors, or insurance offices. One reviewer called it ‘so easy, it was great.’ Another reported a noticeable improvement in energy and mood ‘almost immediately’ after starting treatment.
Clinical evidence lines up with the positive reviews. The Cedars-Sinai study includes a patient who saw AHI drop from 6 to 10 events per hour down to 1 to 3 events per hour with Daybreak. That patient described the device as having ‘effectively managed my mild OSA’ and praised the company’s support team for explaining the results clearly.
What Are Common Daybreak Complaints?
Common Daybreak complaints center on delivery delays, unreturned communications, and cases where the device failed to produce the promised AHI reduction. Several Trustpilot reviewers from 2026 reported waiting more than two months with no device delivered and no status updates. One reviewer wrote, ‘I am over 2 months in and still no device or response.’
Pain and device fit issues appear in a subset of reviews. A MAUDE adverse event report described a patient who experienced significant pain and could not get phone or email support to resolve it. The same report noted the device failed to reduce AHI from a baseline of 13 events per hour. An independent sleep study confirmed the device had not treated the apnea.
Billing disputes show up in the most critical reviews. One MAUDE report described a patient who paid $1,800 (USD) for the device and received a promise of $600 (USD) back through insurance. The reimbursement never arrived. The reviewer filed an adverse event report with the FDA and described Daybreak’s practices as ‘fraudulent.’
Common Complaints:
- Delivery delays beyond the 42-day median timeline
- Missed or unanswered customer service contacts
- Device failing to reduce AHI in some cases
- Insurance reimbursement promises that went unfulfilled
- Pain with the device and difficulty getting support to resolve it
How Does Daybreak Compare to Other Sleep Apnea Devices?
Daybreak sits between over-the-counter snoring mouthpieces and CPAP machines in terms of clinical depth, prescription requirements, and cost. The device is custom-fit and requires a physician prescription, unlike boil-and-bite mouthpieces purchased at pharmacies. The treatment pathway is fully remote, unlike traditional oral appliance therapy delivered through dental offices.
Here is how the categories shake out. OTC mouthpieces treat snoring but are not intended for diagnosed OSA. CPAP treats all severities of OSA but requires a mask. Custom MADs like Daybreak treat mild-to-moderate OSA without a mask. Each level involves different costs, processes, and clinical oversight.
Daybreak’s telehealth model occupies a specific niche. Patients with diagnosed mild-to-moderate OSA who want to avoid CPAP and dental office visits are the primary target. The device is not suitable for severe OSA. Complex cases should not use Daybreak as a replacement for specialist evaluation.
Device Comparison:
| Device Type | Target Condition | Prescription Required | Approximate Cost (USD) |
|---|---|---|---|
| OTC snoring mouthpiece | Snoring only | No | $50 to $150 |
| Daybreak (custom MAD) | Mild-to-moderate OSA | Yes | ~$1,800 (before insurance) |
| CPAP machine | All OSA severities | Yes | $500 to $3,000+ |
Daybreak vs. CPAP: Which Is Better?
CPAP delivers more consistent AHI reduction across all OSA severity levels and remains the primary recommended treatment for moderate-to-severe obstructive sleep apnea. A two-year clinical follow-up found CPAP produced lower AHI scores than oral appliances overall. Both treatments, however, delivered comparable improvements in daytime sleepiness and self-reported quality of life at the one-year and two-year marks.
Portability is where Daybreak wins. The device requires no electricity, no mask, no tubing, and no machine. It fits into a small travel case. Patients who use CPAP at home but struggle with CPAP during travel often find an oral appliance works well as a travel alternative.
The clinical guidance is clear. Patients with severe OSA should start with CPAP. Patients with mild-to-moderate OSA who have documented difficulty tolerating CPAP are candidates for a custom MAD like Daybreak. A sleep physician should make this call using the patient’s AHI score and CPAP compliance history.
Daybreak vs. Over-the-Counter MADs?
Daybreak is a clinically dispensed, prescription-required mandibular advancement device that treats diagnosed OSA, while over-the-counter mouthpieces like VitalSleep are FDA-cleared for snoring only and are not intended for OSA treatment. The clinical distinction matters. Using a snoring mouthpiece for diagnosed OSA does not manage the condition medically.
Custom fit is the primary clinical advantage. Daybreak’s dental impressions create a device molded exactly to the patient’s teeth. OTC devices use boil-and-bite methods for a general approximation of fit. Precision fit produces more consistent jaw advancement and better airway management over time.
Price differences are significant. OTC mouthpieces cost $50 to $150 (USD). Daybreak costs approximately $1,800 (USD) before insurance coverage. For patients with diagnosed OSA and insurance, Daybreak’s net cost may be comparable or lower than repeated OTC device replacements. For patients with snoring only, an OTC device is the appropriate and less expensive starting point.
What Are the Side Effects of the Daybreak Device?
Daybreak acknowledges that minor side effects like jaw soreness may occur, particularly during the early titration phase when the jaw is adapting to the new resting position. Jaw soreness typically appears in the first few weeks. Most patients report it subsides as the jaw adjusts. The titration protocol, which increases advancement slowly in 1-millimeter increments, is designed to minimize discomfort.
Dental professionals have raised longer-term concerns. Dentists commenting in Sleep Review noted patients should be monitored for TMJ complications and bite changes. Proper fitting and clinical oversight from a dentist trained in sleep medicine reduce these risks. Daybreak’s virtual model may limit hands-on monitoring in some cases.
Pain that persists beyond the initial adjustment period warrants professional evaluation. A MAUDE adverse event report described one patient who experienced severe pain and could not get adequate support through Daybreak’s remote care system. That patient eventually sought care through a separate sleep physician and transitioned to CPAP.
Who Should Avoid the Daybreak Device?
Patients with severe OSA should not use Daybreak as a primary treatment without physician guidance and documented trial of CPAP, as mandibular advancement devices cannot consistently achieve the AHI reductions severe OSA requires. Severe OSA involves high-frequency breathing pauses that require more forceful airway management than jaw repositioning alone provides.
Active TMJ disorder is another contraindication. The device repositions the jaw under sustained mechanical force throughout the night. Existing TMJ problems can worsen without proper screening before fitting. A dentist trained in sleep medicine should evaluate TMJ status before any mandibular advancement device is prescribed.
Central sleep apnea patients should also avoid Daybreak. Central apnea involves a brain signaling failure, not an airway obstruction. Advancing the jaw has no effect on central events. Central sleep apnea requires different treatment, typically managed with adaptive ventilation devices rather than oral appliances.
Is Daybreak FDA Approved for Sleep Apnea?
No. Daybreak is FDA-cleared for mild-to-moderate obstructive sleep apnea and snoring, a different regulatory status than FDA approval. FDA clearance applies to Class II medical devices and requires demonstrating substantial equivalence to a predicate device already on the market. FDA approval requires pre-market clinical trials and applies to higher-risk Class III devices. Mandibular advancement devices fall under the clearance pathway.
FDA clearance is the appropriate and standard pathway for MADs. Daybreak’s WatchPAT at-home sleep test is also FDA-cleared independently. Both products meet the regulatory requirements for their device classifications. Clearance does not mean the product is unregulated. It means it has met the safety and effectiveness standard for its class.
Peer-reviewed clinical evidence supports the FDA-cleared indication. A Cedars-Sinai Medical Center study evaluated 185 patients using Daybreak’s virtual pathway. Results published in the American Journal of Clinical and Medical Research in January 2026 found the device achieved clinically significant AHI reductions in patients with mild and moderate OSA.
Is Daybreak a Legitimate Company?
Yes. Daybreak is a registered medical device company with FDA-cleared products, board-certified physician oversight, and a peer-reviewed clinical study supporting its treatment model. The company operates as a licensed telehealth provider and handles insurance billing for patients. A dental director with board credentials oversees the clinical program. A peer-reviewed study validates the telehealth care pathway.
The company has received legitimate criticism. A MAUDE adverse event report and multiple Trustpilot reviews describe communication failures and billing disputes. Customer service complaints do not disqualify a company from legitimacy. However, the complaints are consistent enough to indicate a service delivery problem worth factoring into the purchase decision.
Daybreak’s virtual care model has been recognized in Sleep Review, a trade publication for sleep medicine professionals. The Cedars-Sinai study was conducted by independent investigators at an academic medical center. The clinical outcomes data published in the peer-reviewed journal has not been disputed by any independent party.
How Much Does Daybreak Sleep Apnea Cost?
Daybreak costs approximately $1,800 (USD) for the full treatment pathway, which covers the home sleep test, dental impressions, custom device fabrication, and titration support. The price reflects the clinical pathway and physician involvement rather than the oral appliance hardware alone. OTC alternatives cost $50 to $150 (USD) but do not include diagnostic or prescriptive elements.
Here’s the good news for most patients: upfront cost does not reflect actual net cost. Daybreak is covered by most medical insurance plans. Insurance typically covers custom mandibular advancement devices for diagnosed OSA under the same durable medical equipment benefit that covers CPAP. Daybreak handles the insurance claims process on behalf of patients.
FSA and HSA funds apply to both the sleep test and the device. The at-home WatchPAT sleep test qualifies as an FSA-eligible medical expense independently. Financing options are also available through the company’s website for patients paying out of pocket.
Is Daybreak Covered by Insurance?
Yes. Daybreak is covered by most medical insurance plans when a board-certified physician prescribes it for diagnosed obstructive sleep apnea. Insurance coverage for custom mandibular advancement devices follows the same durable medical equipment pathway as CPAP. A physician prescription, documented OSA diagnosis, and a documented CPAP failure or contraindication typically support the insurance claim.
Daybreak handles insurance claim filing directly. The company works with most major insurance carriers. Medicare and Medicaid coverage varies by state and plan. Patients should confirm their specific coverage with their insurer before committing to the treatment pathway to avoid surprises at billing.
Coverage Options:
- Most major medical insurance plans for diagnosed OSA
- FSA and HSA accounts for both sleep test and device
- Medicare and Medicaid (varies by plan and state)
- Financing plans for out-of-pocket patients
Is Daybreak Worth the Price?
Daybreak delivers documented clinical results for mild-to-moderate OSA patients who complete the full telehealth treatment pathway. The investment is worthwhile for eligible candidates who have ruled out CPAP. The Cedars-Sinai study found 83% of patients met treatment success criteria. An AHI reduction of 60% to 63% in both patient groups is a meaningful clinical outcome that improves sleep quality and reduces cardiovascular risk.
Value depends on the alternative. In-office oral appliance therapy through a dental sleep medicine specialist involves multiple clinic visits, dentist fees, and insurance coordination that patients manage themselves. Daybreak’s remote model consolidates those steps and handles insurance processing. The convenience factor has real practical value for busy adults.
Customer service inconsistency is the clearest risk factor. The clinical product has solid peer-reviewed support. Service delivery does not. Prospective patients should budget for potential communication delays and keep records of all correspondence with the company throughout the treatment process.
Where Can You Buy the Daybreak Device?
Daybreak is available exclusively through the company’s official website and authorized DME suppliers, as the device requires a physician prescription and cannot be purchased at retail pharmacies. The clinical pathway begins with ordering the at-home sleep test, not the device itself. A prescription must be issued before the custom appliance is fabricated and shipped.
Barber DME Supply Group, a durable medical equipment provider with nationwide service, offers access to the Daybreak oral appliance for patients. DME suppliers handle insurance billing directly and provide additional support for device setup. Patients working through a DME supplier may have more hands-on coordination than ordering directly through the website.
Patients should order through verified channels only. The direct-to-consumer telehealth model means Daybreak sells primarily through its own platform. Purchasing through the official website or an authorized DME supplier ensures clinical oversight and access to the company’s patient care guarantee and warranty coverage.
How Long Does Daybreak Take to Deliver?
Daybreak completes the full treatment pathway in a median of 42 days from initial sleep test to treatment completion, based on the Cedars-Sinai study of 185 patients. The minimum documented completion time was 10 days. Timelines depend on sleep test turnaround, physician review, impression kit shipping, dental lab fabrication, and delivery.
The shipping process adds several steps. After the physician prescribes the device, Daybreak ships an impression kit to the patient. The patient returns the completed impressions by mail. Lab fabrication and outbound device shipping add additional days. Total device-to-door time after prescription can take two to four weeks under normal conditions.
Negative reviews report delivery delays significantly beyond the median. Some users describe waiting more than two months with no device and no updates. Patients experiencing delays recommend proactive contact with Daybreak’s support team early in the process rather than waiting for the company to initiate updates.
Is Daybreak Sleep Apnea Device Worth It?
Daybreak is a clinically validated, FDA-cleared oral appliance that delivers meaningful AHI reductions for mild-to-moderate OSA patients who complete the full telehealth pathway. The Cedars-Sinai study confirms the efficacy claim. Insurance coverage makes it accessible for most patients. The remote model eliminates the clinic visits and referral coordination that make traditional oral appliance therapy difficult to access.
The device is not right for every patient. Severe OSA, active TMJ disorder, or a need for hands-on clinical oversight are reasons to pursue in-person treatment first. Daybreak works best for motivated, organized patients who can manage a remote process independently and document their communications carefully.
Bottom line: the clinical product is sound. The service track record is uneven. Patients who enter the process with realistic expectations, confirm insurance coverage upfront, and stay proactive with communication have the best chance of a smooth experience and the clinical results the Cedars-Sinai data supports.
Should You Try Daybreak for Sleep Apnea?
Daybreak is worth trying for adults with diagnosed mild-to-moderate OSA who have not found CPAP tolerable and prefer a fully remote treatment pathway over in-office dental visits. The 63% AHI reduction in the clinical study and 83% treatment success rate provide strong evidence for the device’s effectiveness. Starting with the at-home sleep test is a low-cost first step for anyone who suspects they have undiagnosed OSA.
Patients already diagnosed with OSA through a physician or sleep lab can proceed directly to the device pathway. Insurance coverage applies to both groups with proper documentation. Daybreak’s team handles prescription coordination and insurance billing, which simplifies the financial side of the process.
The practical test is tolerance for remote processes. Patients comfortable with home impression kits, virtual check-ins, and remote titration will find Daybreak straightforward. Patients who prefer hands-on care from a dentist or sleep specialist should pursue traditional oral appliance therapy through a dental sleep medicine practice instead. Both paths lead to the same device type. The difference is who guides the fitting and follow-up.